(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CITELINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CITELINE

ST13

US500000079103969

Class

9, 16, 41, 42, 44

Filing

79103969

Registration

4762279

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

103

Latest update

05/09/2026

Trademark type

Word

Nice classes

9, 16, 41, 42, 44

Filing date

03/31/2011

Registration date

06/30/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/08/2025

Last transaction

05/09/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

London, GB

Examiner

FENNESSY, EDWARD JOHN

Law office

L10

Current location

TMEG LAW OFFICE 101

Holders and representatives

Holders

PHARMA INTELLIGENCE U.K. LIMITED
Caerus US 1 Inc.
Informa Business Intelligence, Inc.
Citeline, Inc.
Informa UK Limited

Representatives

Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.

Technical classification

Nice Classes

Class 9Class 16Class 41Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Apparatus for recordingtransmission or reproduction of sound or images; blank magnetic data carriersprerecorded magnetic data carriers featuring information and data in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; blank recording optical discs; pre-recorded CDsvideo tapeslaser disks and DVDs featuring information in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; downloadable computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; computer software for the analysis of information and data relating to medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; downloadable electronic publications in the nature of newslettersreportsdirectories and bulletins in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare from databases or the internet; downloadable electronic publications and informationnewslettersreportsdirectories and bulletins in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare provided on-line from databases or the internet; computer programs featuring programming languages in electronic form for use in database management in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; prerecorded magneticelectronic or optical data carriers featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; electronic publicationsinstruction manuals recorded on computer media relating to use of computers and to dataall recorded magneticallyoptically or electronically ; magneticoptical and electronic data recording apparatus for recording of soundimages or data

Class 16

Paper and cardboard; goods made from paper or cardboard not included in other classesboxescartonsstorage containerspackaging containers; printed materialsjournalsnewslettersreportsdirectories featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; printed instructional materials in the field of computer software and programmes; book-binding material; photographs; stationery; printed instructionaleducationalteaching materials in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare

Class 41

Education servicesproviding educational seminarsconferencesclasses and workshops in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Training services in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; entertainment and recreational servicessporting and cultural eventstraining and educational conferencescoursesseminars and exhibitions in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Publishing and issuing of scientific papers in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare; Electronic publishing servicespublication of text and graphic works of others online featuring information on medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare ; the provision of news online in the nature of news agenciesgathering and dissemination of news; Nondownloadable electronic publications in the nature of journalsnewslettersreportsdirectories in the fields of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare via the Internet

Class 42

Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessmentprediction and assessment of health risks to public and private agenciesfacilitiesindividuals and locations following the administration of chemicalbiological radiological or nuclear materials; providing medical informationconsultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy servicesmedicalhygienic and beauty care services; informationconsultancy and advisory services relating to all the aforesaid services; informationconsultancy and advisory services in the field of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare relating to all the aforesaid services provided on-line

Class 44

Medical services; advisory medical services and the provision of medical information; dentistry services; advisory medical services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the field of health risk assessmentprediction and assessment of health risks to public and private agenciesfacilitiesindividuals and locations following the administration of chemicalbiological radiological or nuclear materials; providing medical informationconsultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy servicesmedicalhygienic and beauty care services; informationconsultancy and advisory services relating to all the aforesaid services; informationconsultancy and advisory services in the field of medical researchclinical trialspharmaceutical research and developmentpharmaceutical drug development serviceshealthcare relating to all the aforesaid services provided on-line

Publications

History of USPTO decisions and trademark events.

103 publications found

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

05/08/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

09/08/2025

71AG

REGISTERED-SEC.71 ACCEPTED

09/08/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/08/2025

ES71

TEAS SECTION 71 RECEIVED

06/02/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/30/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/30/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/30/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/30/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/30/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/30/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/04/2025

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/29/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

09/19/2024

INPC

INVALIDATION PROCESSED

09/19/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

09/13/2024

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/30/2024

DCPN

CHANGE OF OWNER RECEIVED FROM IB

03/07/2024

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

01/12/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/12/2024

PRAN

POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED

01/12/2024

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

01/12/2024

PRA7

REGISTERED - SEC. 7 REQUEST ABANDONED

01/12/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/10/2024

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

03/24/2023

CHLD

CHANGE OF OWNER RECEIVED FROM IB

02/25/2023

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

02/07/2023

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

12/06/2022

ES7R

TEAS SECTION 7 REQUEST RECEIVED

11/30/2022

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

06/07/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/06/2022

ES75

TEAS SECTION 71 & 15 RECEIVED

12/29/2021

RNWL

INTERNATIONAL REGISTRATION RENEWED

05/20/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/30/2020

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/26/2017

CHLD

CHANGE OF OWNER RECEIVED FROM IB

01/05/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/04/2016

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/17/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/26/2015

FIMP

FINAL DISPOSITION PROCESSED

10/26/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/30/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

06/30/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/14/2015

PUBO

PUBLISHED FOR OPPOSITION

04/14/2015

GPNX

NOTIFICATION PROCESSED BY IB

04/10/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/25/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/25/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/25/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/06/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2015

ALIE

ASSIGNED TO LIE

01/20/2015

CHLD

CHANGE OF OWNER RECEIVED FROM IB

10/16/2014

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/16/2014

GNSL

LETTER OF SUSPENSION E-MAILED

07/16/2014

CNSL

SUSPENSION LETTER WRITTEN

07/16/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2014

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/08/2014

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

01/09/2014

GNFR

FINAL REFUSAL E-MAILED

01/09/2014

CNFR

FINAL REFUSAL WRITTEN

01/09/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/23/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/23/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/23/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/28/2013

GNRT

NON-FINAL ACTION E-MAILED

06/28/2013

CNRT

NON-FINAL ACTION WRITTEN

06/28/2013

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/28/2013

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/28/2013

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/28/2013

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/20/2013

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/05/2013

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/03/2013

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/03/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/27/2012

GNRT

NON-FINAL ACTION E-MAILED

11/27/2012

CNRT

NON-FINAL ACTION WRITTEN

11/27/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/01/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2012

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

10/31/2012

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/08/2012

GNSL

LETTER OF SUSPENSION E-MAILED

06/08/2012

CNSL

SUSPENSION LETTER WRITTEN

06/08/2012

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

06/06/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/25/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/25/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/09/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/09/2012

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/09/2012

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

05/04/2012

RFNT

REFUSAL PROCESSED BY IB

12/19/2011

RFNT

REFUSAL PROCESSED BY IB

11/27/2011

MAFR

APPLICATION FILING RECEIPT MAILED

11/11/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/10/2011

RFRR

REFUSAL PROCESSED BY MPU

11/10/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/10/2011

CNRT

NON-FINAL ACTION WRITTEN

11/09/2011

RFRR

REFUSAL PROCESSED BY MPU

11/08/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/08/2011

CNRT

NON-FINAL ACTION WRITTEN

11/07/2011

DOCK

ASSIGNED TO EXAMINER

11/07/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/07/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/03/2011

Continuous trademark protection

Get notified about every new filing that threatens CITELINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.